Sep 22 2010
Nano Mask, Inc. ("Nano Mask") () today announced that it has launched a complete line of Nano Silver Technology Hospital Curtains which is being manufactured by an ISO 2010 certified manufacturer. The complete line is now available for sale in the United States and Europe.
Nano Silver Technology is an antimicrobial colloid composed of silver nanoparticles stabilized by polymer that exhibits excellent antimicrobial efficacy across a wide spectrum of microorganisms. Silver has long been known to inhibit the oxygen exchange in bacteria, killing the bacteria. Nano Silver Technology has been demonstrated to prolong and enhance that effect. Its super charged magnetic attraction pulls the abnormal DNA of viruses, so it cannot reproduce, thus killing viruses.
In testing, Nano Silver Technology testing has demonstrated the ability to eradicate MRSA (Methicillin-resistant Staphylococcus aureus), Staphylococcus aureus, ATCC 6538P and Klebsiella pneumonia and ATCC 4352. In addition, the Nano Silver Curtains are Flame proof (Type C); Anti-static; Dust proof; Disposable; Recyclable; Mildew proof and are available in three different styles and 13 different colors.
Nano Mask believes that the introduction of this advanced anti-bacterial technology may reduce the risk to patients, staff and visitors of hospital-acquired infections by eliminating certain pathogens, molds and fungi that come into contact with the curtain.
In most cases Nano Mask believes its Nano Silver Technology Curtains offer a considerable cost saving when compared to conventional systems and will not only help to saves lives and reduce clinical costs (including infection treatment costs), but will also reduce capital, labor and laundry costs. Nano Mask plans to launch this product in the United States and international markets immediately through its network of distributors and manufacturers' representatives servicing the hospital market.
"This latest agreement represents yet another effort to generate revenues through our existing network of distributors and manufacturer representatives," said Edward J. Suydam, President and CEO, Nano Mask. "As previously mentioned, we continue to work on developing our proprietary NanoMask(TM) respirator, but we will proceed with any medical products related ventures which we believe could create revenues."
Source: http://www.nanoprotectionsolutions.com/